Charles Schwab Investment Management Inc Galera Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $519 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$2.5 - $3.42 $40,905 - $55,958
16,362 New
16,362 $51,000
Q2 2021

Aug 16, 2021
SELL
$6.08 - $10.44 $139,195 - $239,013
-22,894 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$8.35 - $12.39 $33,909 - $50,315
4,061 Added 21.56%
22,894 $202,000
Q2 2020

Aug 14, 2020
BUY
$7.14 - $14.41 $134,467 - $271,383
18,833 New
18,833 $135,000

Others Institutions Holding GRTX

# of Institutions
3
Shares Held
961K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $2.15M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email